Top Midday Decliners

MT Newswires Live07-09 02:07

Chemomab Therapeutics (CMMB) and Scipher Medicine have entered into an all-stock merger agreement, the companies said Wednesday.

Shares of Chemomab dropped 14% as intraday trading volume jumped to over 1.79 million from a daily average of about 75,000.

Saratoga Investment (SAR) reported a decline in fiscal Q1 net investment income per share late Tuesday, falling more than the market had anticipated.

Shares declined 13%, with intraday trading volume at over 645,000 after midday versus a daily average of about 101,000.

FuelCell Energy's (FCEL) shares slumped 11% amid heavy trading after the company said it priced an offering of about 10.7 million common shares at $21 each for gross proceeds of about $225 million.

More than 14.9 million shares of the company traded intraday compared with a daily average of about 11.3 million.

Price: 1.85, Change: -0.92, Percent Change: -33.21

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment